FDA Advisers Vote in Favor of Moderna, Pfizer/BioNTech Vaccine Emergency Use Authorization in Kids

Yesterday, vaccine advisers with the FDA voted unanimously to expand the emergency use authorization for the Moderna and Pfizer/BioNTech vaccines for children as young as 6 months. All members of the FDA’s Vaccines and Related Biological Products Advisory Committee voted in favor on if the scientific evidence shows the benefits of the Moderna vaccine when administered as a 2-dose series outweigh its risks. They also voted on the benefits and risks of the Pfizer/BioNTech vaccine being administered as a 3-dose series. The FDA will now decide whether to authorize the vaccines for emergency use in the age group and the CDC will also need to vote on whether to recommend them. CDC vaccine advisers are expected to vote on Saturday and the White House says the shots could begin as early as next week.